Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
NuCana PLC banner

NuCana PLC
NASDAQ:NCNA

Watchlist Manager
NuCana PLC Logo
NuCana PLC
NASDAQ:NCNA
Watchlist
Price: 2.09 USD -12.18% Market Closed
Market Cap: $9.3m
Write Note Create Alert Ask AI

NuCana PLC
Investor Relations

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. The firm is focused on developing treatments for cancer patients using its ProTide technology. ProTide are designed to overcome cancer resistance mechanism and generate anti-cancer metabolites in cancer cells. The firm's pipeline includes Acelari, NUC-3373, and NUC-7738. Its ProTide candidates Acelari and NUC-3373 are chemical entities derived from the nucleotide analog and 5- fluorouracil, which are used as chemotherapy agents for the treatment of cancer. Acelari is in a Phase III study for patients with biliary tract cancer. NUC-3373 is in Phase I study for the treatment of a range of patients with solid tumors and a Phase I b study for patient with metastatic colorectal cancer. Its third ProTide candidate, NUC-7738, is a nucleotide analog (3’-deoxyadenosine) and is in Phase I study for patients with solid tumors.

Show more
Loading
NCNA
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Hugh Stephen Griffith
Founder, CEO & Executive Director
No Bio Available
Mr. Donald Munoz
Chief Financial Officer
No Bio Available
Mr. David Harrison
Head of Translational Medicine
No Bio Available
Dr. Jeffrey D. Bloss F.A.C.O.G., M.D.
Chief Medical Officer
No Bio Available
Ms. Theresa Bruce
Senior Vice President of Clinical Operations
No Bio Available
Ms. Elisabeth Oelmann
Senior Vice President of Medical & Clinical Development
No Bio Available
Mr. John-Paul Gallivan
Senior VP of Strategy & Lifecycle Management
No Bio Available
Mr. Gordon Kennovin
Senior VP of CMC & Development
No Bio Available
Dr. Stuart Grant
Senior Vice President of Regulatory Affairs
No Bio Available
Martin Quinn
Company Secretary
No Bio Available

Contacts

Address
Edinburgh
Lochside House, 3 Lochside Way
Contacts
+4401313571111.0
www.nucana.com
sparklesyt

See Also

Summary
NCNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
NCNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NCNA stock valuation using valuation multiples.
Wall Street Estimates
NCNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NCNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.